But this week,
a rival drug company has announced that they were able to develop a cheaper alternative version of the medicine, and it's only going to cost patients $ 1.
Asahi, howver, viewed it as a move to block
a rival drug company.
Not exact matches
Sarepta Therapeutics, which won a pioneering Food and
Drug Administration approval for its Duchenne muscular dystrophy drug last year, has settled a patent dispute with rival BioMarin over the «exon - skipping» technology at heart of the companies» muscular dystrophy treatme
Drug Administration approval for its Duchenne muscular dystrophy
drug last year, has settled a patent dispute with rival BioMarin over the «exon - skipping» technology at heart of the companies» muscular dystrophy treatme
drug last year, has settled a patent dispute with
rival BioMarin over the «exon - skipping» technology at heart of the
companies» muscular dystrophy treatments.
Celgene's patents likely won't be challenged by its
rivals anytime soon — its three main patents expire in the 2020s, by which point the
company will have made a considerable amount of money on the
drugs.
Since then, the
companies have been scrambling to rack up indications for the
rival drugs, which are both approved for treating melanoma and lung cancer.
Importantly, the deal also means that Gilead / Kite
rival Novartis (which had its own CAR - T
drug approved ahead of Yescarta) and other CAR - T
companies won't be able to get in on Sangamo's platform.
The
company actually beat Wall Street profit estimates largely thanks to its superstar cancer immunotherapy
drug Keytruda, which has been shown to best chemotherapy in helping lung cancer patients live longer and given Merck a leg up over
rivals like Bristol - Myers Squibb's immune therapy Opdivo.
The Labour leader, Ed Miliband, has said that there needs to be a thorough assessment of whether a takeover of the British
drug company, AstraZeneca, by its American
rival, Pfizer, is in the country's national interest.
THE takeover of the British
drugs company Wellcome by its larger
rival Glaxo will create a «leaner and fitter»
company, but the nation's research effort in pharmaceuticals will suffer, a group of MPs say this week.
Magic circle firms take lead roles as Japanese
rival continues push to acquire Irish
drug company Shire